Savara Inc Investments, Fair Value Disclosure
Savara Inc (SVRA) had Investments, Fair Value Disclosure of $0 as of 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:InvestmentsFairValueDisclosure · last filed 2017-05-09
- 2017-03-31: Investments, Fair Value Disclosure $0.00.
- 2016-12-31: Investments, Fair Value Disclosure $2.74M.
- 2016-09-30: Investments, Fair Value Disclosure $6.43M.
- 2016-06-30: Investments, Fair Value Disclosure $10.58M.
| Period end | Investments, Fair Value Disclosure | Investments, Fair Value Disclosure as first filed |
|---|---|---|
| 2017-03-31 | $0.00 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $2.74M 10-Q · filed 2017-05-09 | |
| 2016-09-30 | $6.43M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $10.58M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $13.57M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $17.93M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $17.71M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $22.16M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $21.95M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $21.48M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $17.09M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $20.07M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $19.77M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $18.71M 10-K · filed 2015-03-24 | $18.71M 10-K · filed 2014-03-26 |
| 2013-09-30 | $19.13M 10-Q · filed 2013-11-04 | |
| 2012-12-31 | $14.01M 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |